I'm not confused.
VIP Dx were under the REDLABS USA umbrella
REDLABS was owned and run by Harvey Whittemore
VIPdx was merely the trading name of Redlabs. Redlabs was (as of 2005) part of the Wingfield Nevada Group, which was initially owned in partnership between Harvey Whittemore and Thomas Seeno , and (according to this
document ) by the time that the XMRV tests were being marketed, WNG was wholly in the ownership of Thomas Seeno and two of his relatives. Whittemore appears to have continued in a mangement role after ceding ownership to the Seenos.
VIP Dx offered tests for XMRV to patients
Patients were aware the tests was experimental
Some evidence of what patients were aware of (or could have been aware of ) would be useful - for example did VIPdx publish a rider. And if there was such a rider - surely that makes the post that started this thread wholly redundant, given that a core argument of the posted article is that there is a question of whether or not the VIPdx tests were clinically validated - if the tests were experimental how could they have been clinically validated - both points can not be true. Further, if the tests were known to be experimental, how could VIPdx have received orders for the tests from UK doctors, given that ordering such tests would be of no clinical value to patients ?
Mikovits tried to ascertain internally to the WPI whether the tests were the same ones used in Lombardi et al 2009 When the WPI got fed up with her questioning they sacked her and gagged her
According to Mikovits, that is what happened, some confirmatory evidence would be useful. But the point is anyway irrelevant to the question of clinical validation (which is where this thread starts), clinical validation could never have been achieved without reproducibility of the Lombardi et 2009 results being demonstrated in numerous replication studies. No replication, no clinical validation.
Forums have search engines
New members can use them to catch up with what's been said before on a subject they're interested in
This assumes new members have the slightest interest in flawed arguments from the past. Jace I can't avoid posing this question to you directly - you posted an article at the top of this thread which appears to aim at inquiry into events that have happened in the past - is it really your contention that this article is supposed to be taken at face value, and that anyone who might have questions about the events, is supposed to use old forum postings as an authoritative reference ? Quite honestly despite your protestation to the contrary, you appear very confused, and seem to be spreading that confusion with your postings, would you therefore please at least make it plain which of the followingyou believe is correct and on what evidence you base your belief:
1. Patients purchased VIPdx XMRV tests directly from VIPdx in the full knowledge the tests were experimental.
2. Physicians ordered VIPdx XMRV tests in full knowledge that the tests were of no clinical value, and that their patients were aware that the tests were experimental.
3. Physicians ordered VIPdx XMRV tests in the belief that the test were of clinical value, and that on receiving results of the tests the ordering physicians advised their tested patients on the relevence, signficance and treatment optionsthat followed from having either a negative or postive test for XMRV.
IVI